商业在线社交网络数据与他汀类副作用监测:Facebook聚合提及的初步观察研究
本研究利用Sysomos商业数据挖掘产品,检索2017年1月9日至2月8日美国Facebook上所有提及他汀的内容,评估其用于药品不良反应监测的可行性。25,700条提及中4.3%同时提及典型他汀相关副作用,但方法学弱点限制解读,未来药物警戒或可借鉴此类工具。
要点
- Facebook提及他汀的内容中4.3%同时提及典型副作用。
- 该比例与5-20%患者曾出现副作用的估计不矛盾。
- 无法挖掘帖子全文严重阻碍内容分类。
核心结论
- 商业社交网络数据挖掘工具或可为药物警戒提供信息,但帖子全文不可得严重挑战内容分类。
研究设计与样本
- 利用Sysomos from Datasift/Facebook商业软件即服务数据挖掘产品,检索2017年1月9日至2月8日美国Facebook上所有提及他汀及他汀相关副作用的内容。
主要发现
- 25,700条他汀提及中4.3%同时提及典型他汀相关副作用。
- 该百分比受多重方法学弱点影响,但与5-20%患者曾出现典型副作用的估计不矛盾。
局限性
- 无法挖掘帖子全文,严重阻碍内容分类。
- 多重方法学弱点妨碍对该百分比的解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Surveillance of the safety of prescribed drugs after marketing approval has been secured remains fraught with complications. Formal ascertainment by providers and reporting to adverse-event registries, formal surveys by manufacturers, and mining of electronic medical records are all well-known approaches with varying degrees of difficulty, cost, and success. Novel approaches may be a useful adjunct, especially approaches that mine or sample internet-based methods such as online social networks. METHODS: A novel commercial software-as-a-service data-mining product supplied by Sysomos from Datasift/Facebook was used to mine all mentions on Facebook of statins and stain-related side effects in the US in the 1-month period 9 January 2017 through 8 February 2017. RESULTS: A total of 4.3% of all 25,700 mentions of statins also mentioned typical stain-related side effects. Multiple methodological weaknesses stymie interpretation of this percentage, which is however not inconsistent with estimates that 5-20% of patients taking statins will experience typical side effects at some time. CONCLUSIONS: Future work on pharmacovigilance may be informed by this novel commercial tool, but the inability to mine the full text of a posting poses serious challenges to content categorization.
引用
- Huesch MD. Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook. Drug Saf. 2017. PMID: 28748367. doi:10.1007/s40264-017-0577-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。